Prevalence, awareness, treatment and control of dyslipidemia among adults in Northwestern China: the cardiovascular risk survey

Lipids in Health and Disease

Bang-dang Chen¹  Xiao-mei Li²  Fen Liu¹  Xiang Ma²  Xiang Xie²  Yi-Ning Yang²  Zi-xiang Yu²  Yi-Tong Ma²  Jun-yi Luo² 

[1] Xinjiang Key Laboratory of Cardiovascular Disease Research, Urumqi, Xinjiang, China;Department of Cardiology, First Affiliated Hospital of Xinjiang Medical University, Urumqi, Xinjiang, China

关键词: Control;    Treatment;    Awareness;    Prevalence;    Dyslipidemia;   

Others  :  814703
DOI  :  10.1186/1476-511X-13-4

 received in 2013-10-17, accepted in 2013-12-30,  发布年份 2014

【 摘 要 】

Aim

The aim of this study was to estimate the prevalence, awareness, treatment, and control of dyslipidemia in Xinjiang, China.

Method

Stratified sampling method was used to select a representative sample of the general population including Chinese Han, Uygur, and Kazak in this geographic area. Seven cities were chosen. Based on the government records of registered residences, one participant was randomly selected from each household. The eligibility criterion for the study was ≥ 35 years of age.

Results

A total of 14,618 participants (5,757 Han, 4,767 Uygur, and 4,094 Kazak), were randomly selected from 26 villages in 7 cities. The prevalence of dyslipidemia was 52.72% in the all participants. The prevalence of dyslipidemia was higher in Han than that in the other two ethnic (58.58% in Han, 48.27% in Uygur, and 49.60% in Kazak, P < 0.000). The prevalence of dyslipidemia was higher in men than that in women (56.4% vs. 49.3%, P < 0.000). Among the participants with dyslipidemia, the proportion of those who aware, treat, control of dyslipidemia were 53.67%, 22.51%, 17.09% in Han, 42.19%, 27.78%, 16.20% in Uygur, 37.02%, 21.11%, 17.77% in Kazak.

Conclusion

Dyslipidemia is highly prevalent in Xinjiang. The proportion of participants with dyslipidemia who were aware, treated, and controlled is unacceptably low. These results underscore the urgent need to develop national strategies to improve the prevention, detection, and treatment of dyslipidemia in Xinjiang.

【 授权许可】

   
2014 Luo et al.; licensee BioMed Central Ltd.

【 图 表 】

Figure 1.

【 参考文献 】

• [1]Murray CJ, Lopez AD: Mortality by cause for eight regions of the world: Global Burden of Disease Study. Lancet 1997, 349:1269-1276.
• [2]Moran A, Gu D, Zhao D, Coxson P, et al.: Future cardiovascular disease in china: markov model and risk factor scenario projections from the coronary heart disease policy model-china. Circ Cardiovasc Qual Outcomes 2010, 3:243-252.
• [3]Ford ES, Mokdad AH, Giles WH, et al.: Serum total cholesterol concentrations and awareness, treatment, and control of hypercholesterolemia among US adults: findings from the National Health and Nutrition Examination Survey, 1999 to 2000. Circulation 2003, 107:2185-2189.
• [4]Cai L, Zhang L, Liu A, et al.: Prevalence, awareness, treatment, and control of dyslipidemia among adults in Beijing, China. J Atheroscler Thromb 2012, 19:159-168.
• [5]Wu JY, Duan XY, Li L, et al.: Dyslipidemia in Shanghai, China. Prev Med 2010, 51:412-415.
• [6]He J, Gu D, Reynolds K, et al.: Serum total and lipoprotein cholesterol levels and awareness, treatment, and control of hypercholesterolemia in China. Circulation 2004, 110:405-411.
• [7]Wang L, Tao Y, Xie Z, et al.: Prevalence of metabolic syndrome, insulin resistance, impaired fasting blood glucose, and dyslipidemia in Uygur and Kazak populations. J Clin Hypertens 2010, 12:741-745.
• [8]Yao XG, Frommlet F, Zhou L, et al.: The prevalence of hypertension, obesity and dyslipidemia in individuals of over 30 years of age belonging to minorities from the pasture area of Xinjiang. BMC Public Health 2010, 10:91. BioMed Central Full Text
• [9]Liang DP, Yao XG, Li NF, et al.: Epidemiological survey of lipid levels and factors in Kazakan people over 30-year old in Fukang of Xinjiang. Zhonghua Yu Fang Yi Xue Za Zhi 2011, 45:440-443.
• [10]Xie X, Ma YT, Yang YN, et al.: Polymorphisms in the SAA1/2 gene are associated with carotid intima media thickness in healthy Han Chinese subjects: the Cardiovascular Risk Survey. PLoS One 2010, 5:e13997.
• [11]Xie X, Ma YT, Yang YN, et al.: Alcohol consumption and ankle-to-brachial index: results from the Cardiovascular Risk Survey. PLoS One 2010, 5:e15181.
• [12]Xie X, Ma YT, Yang YN, et al.: Polymorphisms in the SAA1 gene are associated with ankle-to-brachial index in Han Chinese healthy subjects. Blood Press 2011, 20:232-238.
• [13]Yang YN, Xie X, Ma YT, et al.: Type 2 diabetes in Xinjiang Uygur autonomous region, China. PLoS One 2012, 7:e35270.
• [14]Joint Committee for Developing Chinese Guidelines on Prevention and Treatment of Dyslipidemia of Dyslipidemia in Adults: Chinese guidelines on prevention and treatment of dyslipidemia in adults. Chin J Cardiol 2007, 35:390-419.
• [15]Zhao WH, Zhang J, Zhai Y, et al.: Blood lipid profile and prevalence of dyslipidemia in Chinese adults. Biomed Environ Sci 2007, 20:329-335.
• [16]Li LM, Rao KQ, Kong LZ, et al.: A description on the Chinese national nutrition and health survey in 2002. Zhonghua Liu Xing Bing Xue Za Zhi 2005, 26:478-484.
• [17]Zhang L, Qin LQ, Liu AP, et al.: Prevalence of risk factors for cardiovascular disease and their associations with diet and physical activity in suburban Beijing, China. J Epidemiol 2010, 20:237-243.
• [18]Zhai F, He Y, Wang Z, et al.: Status and characteristic of dietary intake of 12 minority nationalities in China. Wei Sheng Yan Jiu 2007, 36:539-541.
• [19]Fan JG, Zhu J, Li XJ, et al.: Prevalence of and risk factors for fatty liver in a general population of Shanghai, China. J Hepatol 2005, 43:508-514.
• [20]Raitakari OT, Leino M, Rakkonen K, et al.: Clustering of risk habits in young adults: the cardiovascular risk in Young Finns Study. Am J Epidemiol 1995, 142:36-44.
• [21]Haffner SM: Diabetes, hyperlipidemia, and coronary artery disease. Am J Cardiol 1999, 83:17F-21F.
• [22]Marques-Vidal P, Arveiler D, Evans A, et al.: Awareness, treatment and control of hyperlipidaemia in middle-aged men in France and northern ireland in 1991-1993: the PRIME study. Prospective epidemiological study of myocardial infarction. Acta Cardiol 2002, 57:117-123.
• [23]Jiang J, Wufuer M, Simayi A, et al.: Cross-sectional study of sociodemographic patterning of risk factors for cardiovascular disease in three isolated-based subgroups of the Uyghur population in Xinjiang, China. BMJ Openin press
• [24]Li N, Wang H, Yan Z, et al.: Ethnic disparities in the clustering of risk factors for cardiovascular disease among the Kazakh, Uygur, Mongolian and Han populations of Xinjiang: a cross-sectional study. BMC Public Health 2012, 12:499. BioMed Central Full Text
• [25]Li JH, Wang LM, Mi SQ, et al.: Awareness rate, treatment rate and control rate of dyslipidemia in Chinese adults, 2010. Zhonghua Yu Fang Yi Xue Za Zhi 2012, 46:687-691.